0001209191-18-062929.txt : 20181217
0001209191-18-062929.hdr.sgml : 20181217
20181217161540
ACCESSION NUMBER: 0001209191-18-062929
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181017
FILED AS OF DATE: 20181217
DATE AS OF CHANGE: 20181217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ballance David James
CENTRAL INDEX KEY: 0001755432
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 181238302
MAIL ADDRESS:
STREET 1: C/O PHASEBIO PHARMACEUTICALS, INC.
STREET 2: 1 GREAT VALLEY PKWY., SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2018-10-17
2018-10-17
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001755432
Ballance David James
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
0
1
0
0
VP, Research and Sci. Affairs
Common Stock
6600
D
These shares were omitted from the Reporting Person's Form 3 filed with the Securities and Exchange Commission on October 17, 2018.
/s/ John Sharp, by power of attorney
2018-12-17